+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Teva Pharmaceutical Industries Ltd. - logo

Teva Pharmaceuticals develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company has a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. It currently ranks among the 10 top pharmaceutical companies in the world and is active in 60 countries. Founded in 1901, and based in Israel, Teva employs approximately 58,000 people around the world.

Europe Dystonia Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration, By Type, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Dystonia Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration, By Type, By Country and Growth Forecast, 2022 - 2028

  • Report
  • February 2023
  • 80 Pages
  • Europe
From
Fabry Disease Therapeutic Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Fabry Disease Therapeutic Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2022
  • 95 Pages
  • Global
From
Narcolepsy Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Narcolepsy Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2022
  • 99 Pages
  • Global
From
Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition - Product Thumbnail Image

Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition

  • Report
  • June 2021
  • 55 Pages
  • Global
From
Neuromyelitis Optica Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Neuromyelitis Optica Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 104 Pages
  • Global
From
Huntingtons Disease Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Huntingtons Disease Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 84 Pages
  • Global
From
Europe Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

  • Report
  • August 2022
  • 70 Pages
  • Europe
From
LAMEA Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

  • Report
  • August 2022
  • 70 Pages
  • Africa, Middle East
From
Asia Pacific Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

  • Report
  • August 2022
  • 70 Pages
  • Asia Pacific
From
North America Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

  • Report
  • August 2022
  • 61 Pages
  • North America
From
Use of Artificial Intelligence in Pharmaceutical Supply Chains, Sales and Marketing: Case Study - Product Thumbnail Image

Use of Artificial Intelligence in Pharmaceutical Supply Chains, Sales and Marketing: Case Study

  • Report
  • January 2021
  • 43 Pages
  • Global
From
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 99 Pages
  • Global
From
Rheumatoid Arthritis (RA) Therapy Area Report - Product Thumbnail Image

Rheumatoid Arthritis (RA) Therapy Area Report

  • Report
  • February 2022
  • 65 Pages
  • Global
Pharmaceutical Industry in the United States 2022 - Product Thumbnail Image

Pharmaceutical Industry in the United States 2022

  • Report
  • September 2022
  • 150 Pages
  • United States
From
C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 71 Pages
  • Global
From
Drug Overdose Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Drug Overdose Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 76 Pages
  • Global
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
Sustainability in Pharma - Thematic Research - Product Thumbnail Image

Sustainability in Pharma - Thematic Research

  • Report
  • January 2021
  • 53 Pages
  • Global
From
Asia Pacific Brain Health Supplements Market By Product, By Application, By Country, Industry Analysis and Forecast, 2020 - 2026 - Product Thumbnail Image

Asia Pacific Brain Health Supplements Market By Product, By Application, By Country, Industry Analysis and Forecast, 2020 - 2026

  • Report
  • February 2021
  • 64 Pages
  • Asia Pacific
From
Drug Overview: Fasenra - Product Thumbnail Image

Drug Overview: Fasenra

  • Report
  • February 2018
  • 23 Pages
  • Global
From
Loading Indicator